3 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 3 |
Follow Mitoxantrone: new trials by email Literature Review of Mitoxantrone trials Research Report on Mitoxantrone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia high dose ARA-C, standard dose ARA-C - Acute Myeloid Leukemia | Phase 4 | Unknown | National Research Center for Hematology, Russia | 245 | 2010-01-01 | 2014-04-07 |
| Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders Mitoxantrone - Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorders | Phase 4 | Unknown | Xuanwu Hospital, Beijing | 50 | 2009-03-01 | 2013-12-27 |
| AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia all-trans retinoid acid, idarubicin, mitoxantrone - Leukemia, Promyelocytic, Acute | Phase 4 | Unknown | Technische Universität Dresden | 80 | 2000-01-01 | 2011-07-11 |
Leukemia, Myeloid, Acute (1) · Leukemia, Promyelocytic, Acute (1) · Neuromyelitis Optica (1) · Recurrence (1)
National Research Center for Hematology, Russia (1) · Technische Universität Dresden (1) · Xuanwu Hospital, Beijing (1)
China (1) · Germany (1) · Russia (1)
Gerhard Ehninger, MD (1) · Huiqing Dong, Doctor (1) · Valeriy G Savchenko (1)